25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Inhalerx Ltd
Buy, Hold or Sell?

Let's analyze Inhalerx together

I guess you are interested in Inhalerx Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Inhalerx Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Inhalerx Ltd

I send you an email if I find something interesting about Inhalerx Ltd.

1. Quick Overview

1.1. Quick analysis of Inhalerx (30 sec.)










1.2. What can you expect buying and holding a share of Inhalerx? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.00
Expected worth in 1 year
A$0.00
How sure are you?
29.0%

+ What do you gain per year?

Total Gains per Share
A$0.00
Return On Investment
-11.1%

For what price can you sell your share?

Current Price per Share
A$0.03
Expected price per share
A$0.02 - A$0.04
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Inhalerx (5 min.)




Live pricePrice per Share (EOD)
A$0.03
Intrinsic Value Per Share
A$0.03 - A$0.04
Total Value Per Share
A$0.03 - A$0.04

2.2. Growth of Inhalerx (5 min.)




Is Inhalerx growing?

Current yearPrevious yearGrowGrow %
How rich?-$34.7k$858.1k-$653k-318.4%

How much money is Inhalerx making?

Current yearPrevious yearGrowGrow %
Making money-$128k-$607.3k$479.2k374.2%
Net Profit Margin-305.7%-2,257.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Inhalerx (5 min.)




2.4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#295 / 324

Most Revenue
#294 / 324

Most Profit
#123 / 324

Most Efficient
#270 / 324
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Inhalerx?

Welcome investor! Inhalerx's management wants to use your money to grow the business. In return you get a share of Inhalerx.

First you should know what it really means to hold a share of Inhalerx. And how you can make/lose money.

Speculation

The Price per Share of Inhalerx is A$0.03. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Inhalerx.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Inhalerx, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.00. Based on the TTM, the Book Value Change Per Share is A$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Inhalerx.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-3.9%0.00-2.0%0.00-8.2%0.00-4.9%0.00-5.2%
Usd Book Value Change Per Share0.000.0%0.00-1.9%0.00-2.9%0.00-0.9%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.00-1.9%0.00-2.9%0.00-0.9%0.000.0%
Usd Price Per Share0.02-0.02-0.04-0.04-0.05-
Price to Earnings Ratio-3.58--81.59--4.76--24.00--19.13-
Price-to-Total Gains Ratio-6,798.83-196.29--1,516.85--1,100.03-
Price to Book Ratio-101.56--70.46-10.60--3.92--0.22-
Price-to-Total Gains Ratio-6,798.83-196.29--1,516.85--1,100.03-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.020055
Number of shares49862
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (49862 shares)-27.78-13.64
Gains per Year (49862 shares)-111.13-54.55
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-111-1210-55-65
20-222-2320-109-120
30-333-3430-164-175
40-445-4540-218-230
50-556-5650-273-285
60-667-6760-327-340
70-778-7870-382-395
80-889-8980-436-450
90-1000-10090-491-505
100-1111-11200-545-560

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.031.00.00.0%0.031.00.00.0%
Book Value Change Per Share1.02.01.025.0%3.05.04.025.0%7.06.07.035.0%9.011.011.029.0%9.011.011.029.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.031.00.0%0.00.031.00.0%
Total Gains per Share1.02.01.025.0%3.05.04.025.0%7.06.07.035.0%9.011.011.029.0%9.011.011.029.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Inhalerx Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0.0010%-0.0010%0.0000%0.0000%
Book Value Per Share--0.0000.001-117%0.006-104%0.006-104%0.010-103%
Current Ratio--0.9191.325-31%4.475-79%4.545-80%5.876-84%
Debt To Asset Ratio--1.0890.834+31%0.285+282%0.365+198%0.283+286%
Debt To Equity Ratio---0.571-100%0.448-100%0.414-100%0.322-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.002-0.001-48%-0.004+110%-0.002+27%-0.002+35%
Free Cash Flow Per Share--0.000-0.001+683%-0.005+5138%-0.002+2657%-0.002+2714%
Free Cash Flow To Equity Per Share---0.0010.000-87%-0.002+168%0.000-292%-0.001-32%
Gross Profit Margin--1.2151.757-31%1.116+9%1.280-5%1.307-7%
Intrinsic Value_10Y_max--0.043--------
Intrinsic Value_10Y_min--0.032--------
Intrinsic Value_1Y_max---0.008--------
Intrinsic Value_1Y_min---0.008--------
Intrinsic Value_3Y_max---0.016--------
Intrinsic Value_3Y_min---0.015--------
Intrinsic Value_5Y_max---0.011--------
Intrinsic Value_5Y_min---0.011--------
Market Cap6335460.000+17%5279550.0007760938.500-32%11403828.000-54%13039432.590-60%16818261.987-69%
Net Profit Margin---6.076-3.057-50%-22.574+272%-284.712+4586%-190.652+3038%
Operating Margin---18.949-6.565-65%-23.584+24%-133.706+606%-89.024+370%
Operating Ratio--6.2433.886+61%28.409-78%211.868-97%144.093-96%
Pb Ratio-121.869-20%-101.557-70.457-31%10.601-1058%-3.915-96%-0.222-100%
Pe Ratio-4.295-20%-3.579-81.593+2180%-4.759+33%-24.003+571%-19.129+434%
Price Per Share0.030+17%0.0250.037-32%0.054-54%0.062-60%0.080-69%
Price To Free Cash Flow Ratio-87.021-20%-72.517-58.652-19%-3.891-95%-18.153-75%-15.556-79%
Quick Ratio--0.7500.932-20%3.987-81%4.184-82%5.571-87%
Return On Assets---0.634-0.322-49%-0.643+1%-0.491-23%-0.375-41%
Return On Equity----0.0080%-1.0140%-0.6790%-0.5070%
Total Gains Per Share----0.0010%-0.0010%0.0000%0.0000%
Usd Book Value---34752.641205105.995-117%858172.669-104%872009.316-104%1352946.701-103%
Usd Book Value Change Per Share----0.0010%-0.0010%0.0000%0.0000%
Usd Book Value Per Share--0.0000.001-117%0.004-104%0.004-104%0.006-103%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.001-0.001-48%-0.002+110%-0.001+27%-0.002+35%
Usd Free Cash Flow---12167.369-95329.437+683%-637382.328+5138%-335461.690+2657%-342418.876+2714%
Usd Free Cash Flow Per Share--0.0000.000+683%-0.003+5138%-0.002+2657%-0.002+2714%
Usd Free Cash Flow To Equity Per Share---0.0010.000-87%-0.002+168%0.000-292%0.000-32%
Usd Market Cap4235255.010+17%3529379.1755188187.387-32%7623459.018-54%8716860.686-60%11243008.138-69%
Usd Price Per Share0.020+17%0.0170.025-32%0.036-54%0.041-60%0.053-69%
Usd Profit---246534.778-128089.447-48%-607372.694+146%-377205.437+53%-373114.175+51%
Usd Revenue--40576.613148273.969-73%79457.576-49%56130.636-28%57061.435-29%
Usd Total Gains Per Share----0.0010%-0.0010%0.0000%0.0000%
 EOD+6 -1MRQTTM+7 -21YOY+17 -115Y+13 -1510Y+13 -15

3.3 Fundamental Score

Let's check the fundamental score of Inhalerx Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-4.295
Price to Book Ratio (EOD)Between0-1-121.869
Net Profit Margin (MRQ)Greater than0-6.076
Operating Margin (MRQ)Greater than0-18.949
Quick Ratio (MRQ)Greater than10.750
Current Ratio (MRQ)Greater than10.919
Debt to Asset Ratio (MRQ)Less than11.089
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.634
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Inhalerx Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.900
Ma 20Greater thanMa 500.027
Ma 50Greater thanMa 1000.029
Ma 100Greater thanMa 2000.027
OpenGreater thanClose0.028
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Inhalerx Ltd

InhaleRx Limited engages in the developing and commercializing of medical drug delivery systems in Australia. It also develops inhaled drug formulations. The company was formerly known as Lifespot Health Ltd and changed its name to InhaleRx Limited in October 2021. InhaleRx Limited was incorporated in 2016 and is based in Melbourne, Australia.

Fundamental data was last updated by Penke on 2024-11-01 23:45:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Inhalerx earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Inhalerx to the Medical Devices industry mean.
  • A Net Profit Margin of -607.6% means that $-6.08 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Inhalerx Ltd:

  • The MRQ is -607.6%. The company is making a huge loss. -2
  • The TTM is -305.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-607.6%TTM-305.7%-301.9%
TTM-305.7%YOY-2,257.4%+1,951.7%
TTM-305.7%5Y-28,471.2%+28,165.5%
5Y-28,471.2%10Y-19,065.2%-9,406.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-607.6%-11.0%-596.6%
TTM-305.7%-16.0%-289.7%
YOY-2,257.4%-15.5%-2,241.9%
5Y-28,471.2%-17.9%-28,453.3%
10Y-19,065.2%-23.4%-19,041.8%
4.3.1.2. Return on Assets

Shows how efficient Inhalerx is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Inhalerx to the Medical Devices industry mean.
  • -63.4% Return on Assets means that Inhalerx generated $-0.63 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Inhalerx Ltd:

  • The MRQ is -63.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -32.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-63.4%TTM-32.2%-31.2%
TTM-32.2%YOY-64.3%+32.1%
TTM-32.2%5Y-49.1%+16.9%
5Y-49.1%10Y-37.5%-11.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-63.4%-3.1%-60.3%
TTM-32.2%-3.5%-28.7%
YOY-64.3%-3.9%-60.4%
5Y-49.1%-3.1%-46.0%
10Y-37.5%-4.0%-33.5%
4.3.1.3. Return on Equity

Shows how efficient Inhalerx is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Inhalerx to the Medical Devices industry mean.
  • 0.0% Return on Equity means Inhalerx generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Inhalerx Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.8%+0.8%
TTM-0.8%YOY-101.4%+100.6%
TTM-0.8%5Y-67.9%+67.1%
5Y-67.9%10Y-50.7%-17.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--2.7%+2.7%
TTM-0.8%-3.9%+3.1%
YOY-101.4%-4.2%-97.2%
5Y-67.9%-4.6%-63.3%
10Y-50.7%-5.5%-45.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Inhalerx Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Inhalerx is operating .

  • Measures how much profit Inhalerx makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Inhalerx to the Medical Devices industry mean.
  • An Operating Margin of -1,894.9% means the company generated $-18.95  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Inhalerx Ltd:

  • The MRQ is -1,894.9%. The company is operating very inefficient. -2
  • The TTM is -656.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,894.9%TTM-656.5%-1,238.4%
TTM-656.5%YOY-2,358.4%+1,702.0%
TTM-656.5%5Y-13,370.6%+12,714.1%
5Y-13,370.6%10Y-8,902.4%-4,468.1%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,894.9%-14.8%-1,880.1%
TTM-656.5%-18.2%-638.3%
YOY-2,358.4%-13.3%-2,345.1%
5Y-13,370.6%-17.3%-13,353.3%
10Y-8,902.4%-19.8%-8,882.6%
4.3.2.2. Operating Ratio

Measures how efficient Inhalerx is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 6.24 means that the operating costs are $6.24 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Inhalerx Ltd:

  • The MRQ is 6.243. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.886. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.243TTM3.886+2.357
TTM3.886YOY28.409-24.522
TTM3.8865Y211.868-207.982
5Y211.86810Y144.093+67.775
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ6.2431.315+4.928
TTM3.8861.347+2.539
YOY28.4091.340+27.069
5Y211.8681.365+210.503
10Y144.0931.323+142.770
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Inhalerx Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Inhalerx is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 0.92 means the company has $0.92 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Inhalerx Ltd:

  • The MRQ is 0.919. The company is just not able to pay all its short-term debts. -1
  • The TTM is 1.325. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ0.919TTM1.325-0.406
TTM1.325YOY4.475-3.151
TTM1.3255Y4.545-3.220
5Y4.54510Y5.876-1.331
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9192.595-1.676
TTM1.3252.661-1.336
YOY4.4752.997+1.478
5Y4.5453.416+1.129
10Y5.8763.514+2.362
4.4.3.2. Quick Ratio

Measures if Inhalerx is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Inhalerx to the Medical Devices industry mean.
  • A Quick Ratio of 0.75 means the company can pay off $0.75 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Inhalerx Ltd:

  • The MRQ is 0.750. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.932. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.750TTM0.932-0.182
TTM0.932YOY3.987-3.056
TTM0.9325Y4.184-3.252
5Y4.18410Y5.571-1.387
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7501.572-0.822
TTM0.9321.682-0.750
YOY3.9871.903+2.084
5Y4.1842.330+1.854
10Y5.5712.558+3.013
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Inhalerx Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Inhalerx assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Inhalerx to Medical Devices industry mean.
  • A Debt to Asset Ratio of 1.09 means that Inhalerx assets are financed with 108.9% credit (debt) and the remaining percentage (100% - 108.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Inhalerx Ltd:

  • The MRQ is 1.089. The company is just not able to pay all its debts by selling its assets. -1
  • The TTM is 0.834. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ1.089TTM0.834+0.256
TTM0.834YOY0.285+0.549
TTM0.8345Y0.365+0.469
5Y0.36510Y0.283+0.083
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0890.400+0.689
TTM0.8340.400+0.434
YOY0.2850.354-0.069
5Y0.3650.437-0.072
10Y0.2830.457-0.174
4.5.4.2. Debt to Equity Ratio

Measures if Inhalerx is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Inhalerx to the Medical Devices industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Inhalerx Ltd:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.571-0.571
TTM0.571YOY0.448+0.123
TTM0.5715Y0.414+0.157
5Y0.41410Y0.322+0.092
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.559-0.559
TTM0.5710.555+0.016
YOY0.4480.525-0.077
5Y0.4140.633-0.219
10Y0.3220.693-0.371
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Inhalerx generates.

  • Above 15 is considered overpriced but always compare Inhalerx to the Medical Devices industry mean.
  • A PE ratio of -3.58 means the investor is paying $-3.58 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Inhalerx Ltd:

  • The EOD is -4.295. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.579. Based on the earnings, the company is expensive. -2
  • The TTM is -81.593. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.295MRQ-3.579-0.716
MRQ-3.579TTM-81.593+78.014
TTM-81.593YOY-4.759-76.834
TTM-81.5935Y-24.003-57.590
5Y-24.00310Y-19.129-4.874
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-4.295-1.058-3.237
MRQ-3.579-1.321-2.258
TTM-81.593-2.198-79.395
YOY-4.759-2.341-2.418
5Y-24.003-2.067-21.936
10Y-19.129-2.036-17.093
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Inhalerx Ltd:

  • The EOD is -87.021. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -72.517. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -58.652. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-87.021MRQ-72.517-14.503
MRQ-72.517TTM-58.652-13.866
TTM-58.652YOY-3.891-54.760
TTM-58.6525Y-18.153-40.498
5Y-18.15310Y-15.556-2.597
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-87.021-1.489-85.532
MRQ-72.517-1.752-70.765
TTM-58.652-2.233-56.419
YOY-3.891-5.534+1.643
5Y-18.153-3.774-14.379
10Y-15.556-4.762-10.794
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Inhalerx is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of -101.56 means the investor is paying $-101.56 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Inhalerx Ltd:

  • The EOD is -121.869. Based on the equity, the company is expensive. -2
  • The MRQ is -101.557. Based on the equity, the company is expensive. -2
  • The TTM is -70.457. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-121.869MRQ-101.557-20.311
MRQ-101.557TTM-70.457-31.100
TTM-70.457YOY10.601-81.059
TTM-70.4575Y-3.915-66.542
5Y-3.91510Y-0.222-3.693
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-121.8692.075-123.944
MRQ-101.5572.141-103.698
TTM-70.4572.344-72.801
YOY10.6012.926+7.675
5Y-3.9154.079-7.994
10Y-0.2224.603-4.825
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets582
Total Liabilities634
Total Stockholder Equity-52
 As reported
Total Liabilities 634
Total Stockholder Equity+ -52
Total Assets = 582

Assets

Total Assets582
Total Current Assets582
Long-term Assets0
Total Current Assets
Cash And Cash Equivalents 333
Net Receivables 142
Inventory -35
Other Current Assets 142
Total Current Assets  (as reported)582
Total Current Assets  (calculated)582
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities633
Long-term Liabilities0
Total Stockholder Equity-52
Total Current Liabilities
Short-term Debt 319
Accounts payable 146
Other Current Liabilities 169
Total Current Liabilities  (as reported)633
Total Current Liabilities  (calculated)633
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/- 0
Total Stockholder Equity
Common Stock14,076
Retained Earnings -13,907
Accumulated Other Comprehensive Income -221
Other Stockholders Equity 0
Total Stockholder Equity (as reported)-52
Total Stockholder Equity (calculated)-52
+/-0
Other
Cash and Short Term Investments 333
Common Stock Shares Outstanding 189,767
Liabilities and Stockholders Equity 582
Net Debt -14
Net Working Capital -52
Short Long Term Debt Total 319



6.2. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-06-30
> Total Assets 
352
6,353
6,353
5,086
5,086
3,857
3,857
3,091
3,091
2,022
2,022
624
624
714
714
1,904
1,994
3,653
3,653
2,931
2,931
2,085
2,085
2,258
2,258
1,120
1,120
1,577
1,577
582
582
5825821,5771,5771,1201,1202,2582,2582,0852,0852,9312,9313,6533,6531,9941,9047147146246242,0222,0223,0913,0913,8573,8575,0865,0866,3536,353352
   > Total Current Assets 
352
6,041
6,041
4,774
4,774
3,621
3,621
2,560
2,560
1,568
1,568
552
552
657
657
1,900
1,990
3,639
3,639
2,908
2,908
2,071
2,071
2,244
2,244
1,120
1,120
1,577
1,577
582
582
5825821,5771,5771,1201,1202,2442,2442,0712,0712,9082,9083,6393,6391,9901,9006576575525521,5681,5682,5602,5603,6213,6214,7744,7746,0416,041352
       Cash And Cash Equivalents 
273
5,812
5,812
4,516
4,516
3,316
3,316
2,315
2,315
1,320
1,320
425
425
487
487
1,719
1,719
3,451
3,451
2,803
2,803
1,892
1,892
2,133
2,133
526
526
716
716
333
333
3333337167165265262,1332,1331,8921,8922,8032,8033,4513,4511,7191,7194874874254251,3201,3202,3152,3153,3163,3164,5164,5165,8125,812273
       Net Receivables 
0
229
229
138
249
283
283
27
226
184
184
0
95
114
114
74
120
69
69
19
19
21
21
32
32
0
492
0
802
0
142
142080204920323221211919696912074114114950184184226272832832491382292290
       Other Current Assets 
79
0
0
121
10
23
23
219
20
64
64
127
32
41
41
180
2
118
118
84
1
157
157
111
0
594
103
861
59
142
142
14214259861103594011115715718411811821804141321276464202192323101210079
   > Long-term Assets 
0
312
312
312
312
236
236
531
531
454
454
72
72
57
57
4
4
14
14
23
23
14
14
14
14
0
0
0
0
0
0
000000141414142323141444575772724544545315312362363123123123120
       Property Plant Equipment 
0
45
45
54
54
42
42
96
96
84
84
0
0
0
56
0
0
10
10
10
10
0
0
0
0
0
0
0
0
0
0
0000000000101010100056000848496964242545445450
       Goodwill 
0
0
0
0
0
0
0
140
140
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000001401400000000
       Intangible Assets 
0
267
267
141
141
194
194
294
294
370
370
0
0
2
2
4
4
3
3
14
14
14
14
14
14
0
0
0
0
0
0
000000141414141414334422003703702942941941941411412672670
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000000
> Total Liabilities 
82
345
345
554
580
552
552
408
408
346
346
284
284
233
233
580
376
508
508
253
253
336
336
355
330
468
468
911
911
634
634
63463491191146846833035533633625325350850837658023323328428434634640840855255258055434534582
   > Total Current Liabilities 
82
345
345
554
554
552
552
408
408
346
346
284
284
233
233
580
376
508
508
253
253
336
336
355
330
468
468
911
911
633
633
63363391191146846833035533633625325350850837658023323328428434634640840855255255455434534582
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
-20
0
-20
0
-85
0
0
0
-25
0
0
0
0
92
92
560
560
319
319
31931956056092920000-25000-850-200-20000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
560
0
0
005600000000000000000000000000000
       Accounts payable 
52
345
345
118
118
552
552
80
80
346
346
48
48
213
213
125
125
306
306
73
73
149
149
123
97
270
270
184
184
146
146
1461461841842702709712314914973733063061251252132134848346346808055255211811834534552
       Other Current Liabilities 
30
0
0
436
436
0
0
329
329
0
0
236
236
20
20
455
251
202
10
180
180
188
163
233
233
106
106
167
167
169
169
16916916716710610623323316318818018010202251455202023623600329329004364360030
   > Long-term Liabilities 
0
0
0
0
26
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000260000
> Total Stockholder Equity
270
5,945
5,945
4,507
4,507
3,371
3,371
2,683
2,683
1,676
1,676
340
340
481
481
1,324
1,619
3,144
3,144
2,678
2,678
1,748
1,748
1,903
1,928
652
652
665
997
-52
-52
-52-529976656526521,9281,9031,7481,7482,6782,6783,1443,1441,6191,3244814813403401,6761,6762,6832,6833,3713,3714,5074,5075,9455,945270
   Common Stock
301
8,018
8,018
8,018
8,018
8,018
8,018
8,243
8,243
8,243
8,243
8,243
8,243
8,853
8,853
10,455
10,556
12,800
12,800
12,901
12,901
12,901
12,901
13,928
13,928
14,076
14,076
14,076
14,076
14,076
14,076
14,07614,07614,07614,07614,07614,07613,92813,92812,90112,90112,90112,90112,80012,80010,55610,4558,8538,8538,2438,2438,2438,2438,2438,2438,0188,0188,0188,0188,0188,018301
   Retained Earnings -13,907-13,907-13,169-13,169-13,150-13,150-11,695-11,726-10,150-10,150-9,254-9,254-8,700-8,700-7,949-8,143-7,404-7,404-6,938-6,938-5,813-5,813-4,770-4,770-4,161-4,161-3,094-3,094-1,693-1,693-31
   Capital Surplus 0000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000
   Other Stockholders Equity 000000-304-299-1,002-1,002-9690-9560-988-9880000-8,9970000000000



6.3. Balance Sheets

Currency in AUD. All numbers in thousands.




6.4. Cash Flows

Currency in AUD. All numbers in thousands.




6.5. Income Statements

Currency in AUD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,204
Cost of Revenue-0
Gross Profit1,2041,204
 
Operating Income (+$)
Gross Profit1,204
Operating Expense-2,591
Operating Income-1,386-1,386
 
Operating Expense (+$)
Research Development1,448
Selling General Administrative828
Selling And Marketing Expenses33
Operating Expense2,5912,310
 
Net Interest Income (+$)
Interest Income2
Interest Expense-8
Other Finance Cost-0
Net Interest Income-6
 
Pretax Income (+$)
Operating Income-1,386
Net Interest Income-6
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-1,443-1,330
EBIT - interestExpense = -1,432
-2,647
-1,435
Interest Expense8
Earnings Before Interest and Taxes (EBIT)-1,423-1,435
Earnings Before Interest and Taxes (EBITDA)-1,414
 
After tax Income (+$)
Income Before Tax-1,443
Tax Provision-0
Net Income From Continuing Ops-1,443-1,443
Net Income-1,443
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,591
Total Other Income/Expenses Net-576
 

Technical Analysis of Inhalerx
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Inhalerx. The general trend of Inhalerx is NEUTRAL with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Inhalerx's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (0.0%) Bearish trend (0.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Inhalerx Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.04 < 0.04 < 0.04.

The bearish price targets are: 0.021 > 0.02 > 0.02.

Tweet this
Inhalerx Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Inhalerx Ltd. The current mas is .

The long score for the Moving Averages is 7/14.
The longshort score for the Moving Averages is 0/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Inhalerx Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Inhalerx Ltd. The current macd is -0.00018485.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Inhalerx price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Inhalerx. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Inhalerx price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Inhalerx Ltd Daily Moving Average Convergence/Divergence (MACD) ChartInhalerx Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Inhalerx Ltd. The current adx is 38.89.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Inhalerx shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Inhalerx Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Inhalerx Ltd. The current sar is 0.04798157.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Inhalerx Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Inhalerx Ltd. The current rsi is 54.90. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
Inhalerx Ltd Daily Relative Strength Index (RSI) ChartInhalerx Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Inhalerx Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Inhalerx price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Inhalerx Ltd Daily Stochastic Oscillator ChartInhalerx Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Inhalerx Ltd. The current cci is 36.42.

Inhalerx Ltd Daily Commodity Channel Index (CCI) ChartInhalerx Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Inhalerx Ltd. The current cmo is 15.71.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Inhalerx Ltd Daily Chande Momentum Oscillator (CMO) ChartInhalerx Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Inhalerx Ltd. The current willr is -45.45454545.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Inhalerx is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Inhalerx Ltd Daily Williams %R ChartInhalerx Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Inhalerx Ltd.

Inhalerx Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Inhalerx Ltd. The current atr is 0.00221146.

Inhalerx Ltd Daily Average True Range (ATR) ChartInhalerx Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Inhalerx Ltd. The current obv is 5,488,536.

Inhalerx Ltd Daily On-Balance Volume (OBV) ChartInhalerx Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Inhalerx Ltd. The current mfi is 25.61.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Inhalerx Ltd Daily Money Flow Index (MFI) ChartInhalerx Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Inhalerx Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-06-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-07-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-08-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-23CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-29CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-02ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-04ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-11STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Inhalerx Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Inhalerx Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.900
Ma 20Greater thanMa 500.027
Ma 50Greater thanMa 1000.029
Ma 100Greater thanMa 2000.027
OpenGreater thanClose0.028
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Inhalerx with someone you think should read this too:
  • Are you bullish or bearish on Inhalerx? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Inhalerx? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Inhalerx Ltd

I send you an email if I find something interesting about Inhalerx Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Inhalerx Ltd.

Receive notifications about Inhalerx Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.